Tuesday, September 11, 2007

Roche sues Teva in U.S. over generic bone drug (Reuters)

Franz B. Humer, Chairman of the Board and CEO of Roche Holding AG, announces 2003 full year results during a news conference in Basel, February 4, 2004. Swiss drugmaker Roche Holding AG is taking legal action against Israel's Teva Pharmaceutical Industries Ltd  (Georgios Kefalas/Reuters)Reuters - Swiss drugmaker Roche Holding AG is
taking legal action against Israel's Teva Pharmaceutical
Industries Ltd in the United States to prevent Teva
from selling a generic version of Roche osteoporosis drug
Boniva, Roche said on Tuesday.


No comments: